Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) Short Interest Update

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) was the target of a large growth in short interest in May. As of May 28th, there was short interest totalling 3,800 shares, a growth of 3,700.0% from the May 13th total of 100 shares. Based on an average daily trading volume, of 498,900 shares, the short-interest ratio is presently 0.0 days.

Mydecine Innovations Group stock traded down $0.01 during midday trading on Friday, reaching $0.25. The stock had a trading volume of 479,946 shares, compared to its average volume of 1,136,037. Mydecine Innovations Group has a 12 month low of $0.13 and a 12 month high of $0.66. The business has a fifty day moving average price of $0.29.

About Mydecine Innovations Group

Mydecine Innovations Group Inc operates as a biopharma and life sciences company which focuses on research, development, acceptance, and commercialization of alternative nature-sourced medicine for treating mental health problems. Its mental health solutions focuses on clinical trials focusing on veterans; emergency medical services (EMS); first responders with a PTSD indication; and drug discovery and delivery mechanisms.

See Also: What are convertible shares? 

Receive News & Ratings for Mydecine Innovations Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mydecine Innovations Group and related companies with MarketBeat.com's FREE daily email newsletter.